This article is proudly sponsored by Sew Torn, a film by Diamantis Zavitsanos!
Hims & Hers Health (HIMS): The Telehealth Startup Turning Awkward Problems Into a Billion-Dollar Business
The Elevator Pitch: Your Doctor, Your Pharmacy, and Your Confidence… All Online
Hims & Hers is not your grandpa’s healthcare company. It’s a direct-to-consumer telehealth platform that started by selling hair loss meds and erectile dysfunction treatments — and has since expanded into mental health, skincare, primary care, and weight-loss solutions.
It’s healthcare designed for the modern consumer: discreet, subscription-based, and optimized for TikTok attention spans.
How HIMS Actually Makes Money (With Real Examples)
Hims is not just an app with a doctor chat button — it’s a full-stack monetization machine.
1. Subscription Revenue — The Recurring Engine
The vast majority of HIMS’s revenue comes from recurring subscriptions. Users pay monthly for medications, refills, and treatment plans that are delivered right to their doors.
Example: A customer signs up for a monthly plan of finasteride for hair loss — HIMS charges every month, handles the prescription, ships the medication, and pockets a recurring margin.
2. Prescription Medications & Wellness Products
Beyond subscriptions, HIMS sells individual products — from sexual health prescriptions to dermatology creams, supplements, and more.
Example: A one-off acne kit purchase or prescription refill generates product revenue outside the subscription base.
3. Telehealth Consultations
HIMS connects patients with licensed providers for virtual consults, charging either directly or bundling the cost into a subscription.
Example: A patient books an online visit for anxiety management — they get care, HIMS gets revenue, and potentially signs that patient up for a recurring mental health plan.
4. New Verticals — Weight Loss and Multi-Condition Care
HIMS has leaned hard into high-growth categories like weight-loss medications (GLP-1 compounds) and multi-condition care bundles.
Example: A customer enrolls in a combined plan for hair, skin, and weight-loss management, creating a larger monthly bill and locking them in longer term.
5. Cross-Sell and Upsell Flywheel
HIMS uses data and personalization to push more services to existing users — mental health, dermatology, supplements — increasing ARPU (average revenue per user).
Example: A hair loss customer gets targeted to add skincare or vitamin subscriptions, boosting lifetime value without paying for new customer acquisition.
When HIMS Stock Rips
HIMS thrives in the market when:
-
Subscriber Count Jumps: New users drive recurring revenue growth.
-
ARPU Expands: Customers buy more treatments per month, lifting margins.
-
Unit Economics Improve: Marketing spend per new user drops, payback periods shorten.
-
Big Vertical Wins Land: Expansion into weight loss or other hot health categories adds fuel.
-
Gross Margins Expand: Owning more of the supply chain and fulfillment increases profitability.
When HIMS Stock Gets Hit
But HIMS isn’t bulletproof. The stock drops when:
-
Regulation Shifts: FDA or state boards tighten telehealth or compounding rules.
-
Verticals Get Pulled: If HIMS has to phase out weight-loss compounding or shut down segments (like dermatology), growth can slow.
-
Churn Rises: Subscriptions are only good if people stick around — rising cancellations hurt recurring revenue.
-
Marketing Spend Gets Inefficient: If CAC balloons, margins suffer and growth looks too expensive.
-
Competition Intensifies: Traditional health systems, pharmacies, or other telehealth providers step into the same categories.
Why HIMS Has an Edge
-
Brand Power: Hims has successfully destigmatized uncomfortable topics, making it easier for consumers to seek care.
-
Direct-to-Consumer Model: Owning the customer relationship gives higher margins and better data.
-
Recurring Revenue: Subscription-based model smooths cash flow and makes revenue more predictable.
-
Agility: HIMS can pivot quickly into new verticals like GLP-1 weight loss or personalized care plans.
-
Consumer Trust + Experience: Discreet packaging, simple UX, and fast onboarding create loyalty in sensitive health categories.
Risks Worth Watching
-
Regulatory Risk: One rule change could shut down entire verticals (as seen with compounding).
-
Brand Trust: Any misstep in quality, safety, or prescribing could damage credibility.
-
Dependence on Hot Categories: Over-reliance on weight-loss or hair loss treatments could backfire if demand slows.
-
Rising Competition: Big players like Amazon Pharmacy, CVS, and Teladoc could undercut HIMS on price and convenience.
-
Cost Management: Aggressive growth spending can erode profitability if not balanced carefully.
The Take: A Growth Rocket With Turbulence Ahead
HIMS is not your slow-and-steady healthcare dividend play — it’s a high-growth, high-volatility telehealth bet. It’s building a brand moat in sensitive, recurring health categories and monetizing through subscriptions and cross-sells.
If you believe healthcare is going fully digital, if weight-loss treatments remain in massive demand, and if HIMS can keep customer acquisition efficient, this is one of the most exciting growth stories in health tech.
But make no mistake — this is a name where regulation, competition, and churn can hit hard. It’s a stock for growth-oriented investors willing to stomach swings in pursuit of a big payoff.
DISCLAIMER: This analysis of the aforementioned stock security is in no way to be construed, understood, or seen as formal, professional, or any other form of investment advice. We are simply expressing our opinions regarding a publicly traded entity.
© 2025 MacroHint.com. All rights reserved.